vs
Global Indemnity Group, LLC（GBLI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Global Indemnity Group, LLC的1.7倍（$197.9M vs $116.7M），REPLIGEN CORP净利率更高（6.7% vs 5.5%，领先1.2%），REPLIGEN CORP同比增速更快（13.6% vs 7.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 2.0%）
Global Indemnity Group LLC是一家专业保险控股企业，提供定制化商业及个人财产意外险产品、保证保险与再保险解决方案，主要服务美国境内中小微企业及小众个人保险客群，聚焦传统保险覆盖不足的特殊风险领域。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
GBLI vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$116.7M
营收增速更快
RGEN
高出6.0%
7.6%
净利率更高
RGEN
高出1.2%
5.5%
两年增速更快
RGEN
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.7M | $197.9M |
| 净利润 | $6.5M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 7.9% | 9.0% |
| 净利率 | 5.5% | 6.7% |
| 营收同比 | 7.6% | 13.6% |
| 净利润同比 | -28.5% | 143.9% |
| 每股收益（稀释后） | $0.48 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GBLIRGEN
| Q4 25 | $116.7M | $197.9M | ||
| Q3 25 | $114.2M | $188.8M | ||
| Q2 25 | $110.5M | $182.4M | ||
| Q1 25 | $108.7M | $169.2M | ||
| Q4 24 | $108.4M | $174.1M | ||
| Q3 24 | $111.8M | $154.9M | ||
| Q2 24 | $108.7M | $154.1M | ||
| Q1 24 | $112.3M | $151.3M |
净利润GBLIRGEN
| Q4 25 | $6.5M | $13.3M | ||
| Q3 25 | $12.5M | $14.9M | ||
| Q2 25 | $10.3M | $14.9M | ||
| Q1 25 | $-4.0M | $5.8M | ||
| Q4 24 | $9.0M | $-30.3M | ||
| Q3 24 | $12.8M | $-654.0K | ||
| Q2 24 | $10.1M | $3.3M | ||
| Q1 24 | $11.4M | $2.1M |
毛利率GBLIRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率GBLIRGEN
| Q4 25 | 7.9% | 9.0% | ||
| Q3 25 | 14.1% | 8.9% | ||
| Q2 25 | 11.9% | 7.6% | ||
| Q1 25 | -4.7% | 3.9% | ||
| Q4 24 | 11.2% | -17.7% | ||
| Q3 24 | 14.2% | -5.1% | ||
| Q2 24 | 11.7% | 1.0% | ||
| Q1 24 | 12.7% | 1.3% |
净利率GBLIRGEN
| Q4 25 | 5.5% | 6.7% | ||
| Q3 25 | 11.0% | 7.9% | ||
| Q2 25 | 9.4% | 8.2% | ||
| Q1 25 | -3.7% | 3.4% | ||
| Q4 24 | 8.3% | -17.4% | ||
| Q3 24 | 11.4% | -0.4% | ||
| Q2 24 | 9.3% | 2.2% | ||
| Q1 24 | 10.1% | 1.4% |
每股收益（稀释后）GBLIRGEN
| Q4 25 | $0.48 | $0.24 | ||
| Q3 25 | $0.86 | $0.26 | ||
| Q2 25 | $0.71 | $0.26 | ||
| Q1 25 | $-0.30 | $0.10 | ||
| Q4 24 | $0.65 | $-0.55 | ||
| Q3 24 | $0.92 | $-0.01 | ||
| Q2 24 | $0.73 | $0.06 | ||
| Q1 24 | $0.82 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $65.5M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $706.6M | $2.1B |
| 总资产 | $1.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资GBLIRGEN
| Q4 25 | $65.5M | $767.6M | ||
| Q3 25 | $75.4M | $748.7M | ||
| Q2 25 | $67.3M | $708.9M | ||
| Q1 25 | $81.1M | $697.2M | ||
| Q4 24 | $17.0M | $757.4M | ||
| Q3 24 | $31.0M | $784.0M | ||
| Q2 24 | $46.7M | $809.1M | ||
| Q1 24 | $38.9M | $780.6M |
总债务GBLIRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GBLIRGEN
| Q4 25 | $706.6M | $2.1B | ||
| Q3 25 | $704.1M | $2.1B | ||
| Q2 25 | $695.3M | $2.1B | ||
| Q1 25 | $687.1M | $2.0B | ||
| Q4 24 | $689.1M | $2.0B | ||
| Q3 24 | $686.7M | $2.0B | ||
| Q2 24 | $667.5M | $2.0B | ||
| Q1 24 | $659.5M | $2.0B |
总资产GBLIRGEN
| Q4 25 | $1.7B | $2.9B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $1.7B | $2.9B | ||
| Q4 24 | $1.7B | $2.8B | ||
| Q3 24 | $1.8B | $2.8B | ||
| Q2 24 | $1.7B | $2.9B | ||
| Q1 24 | $1.7B | $2.8B |
负债/权益比GBLIRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 1.40× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流GBLIRGEN
| Q4 25 | $9.1M | $25.7M | ||
| Q3 25 | $5.7M | $48.1M | ||
| Q2 25 | $7.0M | $28.6M | ||
| Q1 25 | $2.4M | $15.0M | ||
| Q4 24 | $38.8M | $39.2M | ||
| Q3 24 | $15.3M | $49.3M | ||
| Q2 24 | $14.3M | $42.2M | ||
| Q1 24 | $22.7M | $44.7M |
自由现金流GBLIRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率GBLIRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度GBLIRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率GBLIRGEN
| Q4 25 | 1.40× | 1.93× | ||
| Q3 25 | 0.45× | 3.23× | ||
| Q2 25 | 0.68× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 4.30× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.41× | 12.70× | ||
| Q1 24 | 2.00× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GBLI
| Belmont Core | $99.2M | 85% |
| Agency And Insurance Services | $13.8M | 12% |
| Other | $3.7M | 3% |
RGEN
暂无分部数据
